D. Brennan

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma

A. Maclean, R. Petty, D. Hadley, 2000, Gene Therapy.

Survival in women with ovarian cancer before and after the introduction of adjuvant paclitaxel; a 25-year, single institution review.

G. Flannelly, D. Fennelly, R. Shireen, 2012, Irish medical journal.

N-cadherin haploinsufficiency increases survival in a mouse model of pancreatic cancer

J. Li, A. Witkiewicz, T. Neill, 2012, Oncogene.

SRF617 Is a Potent Inhibitor of CD39 with Immunomodulatory and Antitumor Properties.

A. Dulak, V. Palombella, J. Stagg, 2023, ImmunoHorizons.